Published in Experientia on August 15, 1958
The biochemistry of mental disease. Can Med Assoc J (1961) 0.96
The histochemical identification of acetylcholinesterase in cholinergic, adrenergic and sensory neurons. J Pharmacol Exp Ther (1955) 5.42
The elimination of enzymatic diffusion artifacts in the histochemical localization of cholinesterases and a survey of their cellular distributions. J Pharmacol Exp Ther (1951) 5.23
The histochemical differentiation of types of cholinesterases and their localizations in tissues of the cat. J Pharmacol Exp Ther (1950) 4.80
The histochemical localization of cholinesterases in the central nervous system of the rat. J Comp Neurol (1954) 2.74
A histochemical method for localizing cholinesterase activity. Proc Soc Exp Biol Med (1949) 2.66
The distribution cholinesterases in human skin, with special reference to eccrine and apocrine sweat glands. J Invest Dermatol (1953) 2.13
The physiological role of acetyl-cholinesterase (AChE) in sympathetic ganglia. J Pharmacol Exp Ther (1961) 1.99
A new general concept of the neurohumoral functions of acetylcholine and acetylcholinesterase. J Pharm Pharmacol (1962) 1.86
The cerebral distributions of a tertiary and a quaternary anticholinesterase agent following intravenous and intraventricular injection. J Pharmacol Exp Ther (1956) 1.82
The effect of inhibition of specific and non-specific cholinesterase on the motility of the isolated ileum. J Pharmacol Exp Ther (1950) 1.82
A proposed dual neurohumoral role of acetylcholine: its functions at the pre- and post-synaptic sites. Nature (1961) 1.71
Congenital megacolon; a comparison of the spastic and hypertrophied segments with respect to Cholinesterase activities and sensitivities to Acetylcholine, DFP and the barium ion. Gastroenterology (1953) 1.68
HISTOCHEMICAL CORRELATIONS OF ACETYLCHOLINESTERASE AND CATECHOLAMINES IN POSTGANGLIONIC AUTONOMIC NERVES OF THE CAT, RABBIT, AND GUINEA PIG. J Pharmacol Exp Ther (1965) 1.67
The action of antihistaminics and atropine in blocking the spasmogenic activity of serotonin on the guinea pig ileum. Arch Int Pharmacodyn Ther (1953) 1.59
The localization of external or functional acetylcholinesterase at the synapses of autonomic ganglia. J Pharmacol Exp Ther (1959) 1.58
Cholinesterases of the tissues and sera of rabbits. Biochem J (1953) 1.50
A histochemical study of cholinesterase during formation of the motor end plate of the albino rat. J Exp Zool (1951) 1.44
Comparison of the effects of inhibition of external, internal and total acetylcholinesterase upon ganglionic transmission. J Pharmacol Exp Ther (1959) 1.42
Enzymic formation of noradrenaline in mammalian tissue extracts. Nature (1950) 1.32
The formation of noradrenaline from dihydroxyphenylserine. Br J Pharmacol Chemother (1950) 1.28
The histochemical localization of cholinesterase in ocular tissues. Am J Ophthalmol (1950) 1.27
Enzymes and their substrates in the adrenal gland of the ox. Br J Pharmacol Chemother (1951) 1.25
A possible enzymatic basis for the differential action of mydriatics on light and dark irides. J Physiol (1953) 1.23
Modification of the effects of sympathomimetic amines and of adrenergic nerve stimulation by 1-isonicotinyl-2-isopyropylhydrazine (IIH) and isonicotinic acid hydrazide (INH). J Pharmacol Exp Ther (1956) 1.15
Histochemical demonstration of cholinesterases in the hypothalamus of the dog. J Physiol (1957) 1.13
Localization of acetylcholinesterase in the neurohypophysis and its functional implications. Proc Soc Exp Biol Med (1961) 1.11
Enhancement of inhibitory and excitatory effects of catecholamines. J Pharmacol Exp Ther (1960) 1.09
Noradrenaline in whale suprarenal medulla. J Physiol (1951) 1.08
The relationship between cholinesterase inhibition and ganglionic transmission. J Pharmacol Exp Ther (1952) 1.08
[Kidney damage with cortical necrosis in rats under treatment with 5-oxytryptamin; additional experimental contribution to the question of endocrine activity of carcinoids]. Schweiz Med Wochenschr (1955) 1.03
Localization of specific cholinesterase in ocular tissues of the cat. Am J Ophthalmol (1952) 1.02
The nature of synaptic transmission in the superior cervical ganglion following reinnervation by the afferent vagus. J Pharmacol Exp Ther (1961) 1.01
Mode of regeneration of acetylcholinesterase in cholinergic neurons following irreversible inactivation. J Neurochem (1961) 0.96
[Determination of adrenalin, noradrenalin, decarboxylase activity and amine oxidase activity in cell fractions of pheochromocytomas]. Klin Wochenschr (1956) 0.96
The distribution of choline oxidase activity in rat liver. J Biol Chem (1951) 0.95
Histochemical demonstration of reactivation acetylcholinesterase in vivo. Science (1957) 0.94
ELECTRON MICROSCOPIC LOCALIZATION OF CHOLINESTERASES IN A SYMPATHETIC GANGLION BY A GOLD-THIOLACETIC ACID METHOD. Life Sci (1965) 0.93
Histochemical demonstration of reversible anticholinesterase action at selective cellular sites in vivo. J Pharmacol Exp Ther (1957) 0.93
[Oxytryptamin (Serotonin) as a new hormone; with a special reference to its relation to the syndrome of metastatic carcinoids]. Schweiz Med Wochenschr (1955) 0.93
The cytological localization of intracellular neuronal acetylcholinesterase. J Biophys Biochem Cytol (1959) 0.92
Distribution of glutamic acid decarboxylase activity in human brain. J Neurochem (1962) 0.91
Metabolism of choline and related compounds by hepatic tissue from several species including man. Proc Soc Exp Biol Med (1954) 0.91
[Pronounced thrombocytosis in rats under treatment with 5-oxytryptamin; experimental contribution to the question of endocrine activity of carcinoids]. Schweiz Med Wochenschr (1955) 0.90
In vitro effects of ouabain on slices and mitochondrial preparations from heart and brain. J Pharmacol Exp Ther (1953) 0.90
The cholinergic activity of tetrakis-(dimethylaminomethyl)-methane tetramethobromide. J Pharmacol Exp Ther (1954) 0.89
2-Amino-5-chlorobenzoxazole (McN-485, flexin), a long-acting spinal cord depressant. Proc Soc Exp Biol Med (1955) 0.88
Physiological implications of the histochemical localization of monoamine oxidase. J Physiol (1954) 0.88
THE RELEASE OF ACETYLCHOLINE FROM A SYMPATHETIC GANGLION BY CARBACHOL. RELATIONSHIP TO THE FUNCTIONAL SIGNIFICANCE OF THE LOCALIZATION OF ACETYLCHOLINESTERASE. Can J Biochem Physiol (1963) 0.87
Histochemical demonstration of monoamine oxidase in human skin. J Invest Dermatol (1955) 0.86
Facilitation of ganglionic transmission following inhibition of cholinesterase by DFP. J Pharmacol Exp Ther (1954) 0.85
The destruction of epinephrine by the DOPA-oxidase system of ocular tissue. Science (1952) 0.84
The adrenochrome redox system. Arch Biochem Biophys (1951) 0.84
[Changes in adrenalin and noradrenalin concentrations in human blood plasma under the effects of phentolamine (regitine)]. Helv Physiol Pharmacol Acta (1957) 0.81
[Determination of enzymes and their substrates and reaction products in cell fractions of small intestine carcinoid metastasis and pheochromocytoma]. Acta Neuroveg (Wien) (1957) 0.81
The effect of inhibition of non-specific cholinesterase on perception of tactile sensation in human volar skin. J Invest Dermatol (1958) 0.80
[Noradrenaline and its significance in pharmacology]. Schweiz Med Wochenschr (1959) 0.79
Acetylcholinesterase regeneration in peripheral nerve after irreversible inactivation. Science (1960) 0.78
The use of histochemistry in pharmacological studies. Biochem Pharmacol (1962) 0.78
Reactivation of DFP-inactivated acetylcholinesterase by monoisonitrosoacetone (MINA) and diacetylmonoxime (DAM) in vivo. J Pharmacol Exp Ther (1958) 0.78
Possible mechanisms for the termination of the physiological actions of catecholamines. Pharmacol Rev (1959) 0.77
The relationship between cholinesterase inhibition and the pharmacological action of di-isopropyl fluorophosphate (DFP). J Pharmacol Exp Ther (1946) 0.77
[Decarboxylation of DOPA by the myocardium of guinea pigs]. Klin Wochenschr (1962) 0.76
[Hydroxytryptamine and hydroxyindolacetic acid determination in a case of carcinoid syndrome, with a study on hydroxytryptamine]. Klin Wochenschr (1956) 0.76
Anticholinesterase drugs. J Pharmacol Exp Ther (1949) 0.75
Choline oxidase activity in young rats. Proc Soc Exp Biol Med (1952) 0.75
The acute toxicity of di-isopropyl fluorophosphate. J Pharmacol Exp Ther (1946) 0.75
Current concepts in the management of functional gastrointestinal disorders; transcription of a panel meeting on therapeutics. Bull N Y Acad Med (1954) 0.75
The cardiovascular and respiratory actions of rauwolscine. J Pharmacol Exp Ther (1958) 0.75
The treatment of di-isopropyl fluorophosphate (DFP) poisoning in rabbits. J Pharmacol Exp Ther (1946) 0.75
[Acetylcholine potentiation of adrenalin and nor-adrenalin on the isolated rabbit iris]. Experientia (1955) 0.75
[Amino acid decarboxylase in pheochromocytoma and carcinoid tissue]. Schweiz Med Wochenschr (1962) 0.75
[Determination of enzyme activities in metastatic tissues in case of cancer]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1956) 0.75
[Suppression of hydroxyindole-acetic acid excretion in urine after reserpine administration in humans; with special consideration to carcinoid syndrome]. Schweiz Med Wochenschr (1957) 0.75
FROM THE LINTEL. Am J Pharm Sci Support Public Health (1965) 0.75
Structure of the motor endplate. Am J Med (1955) 0.75
[Clinical manifestations and detection of 5-hydroxy-indolacetic acid and 5-hydroxy-tryptamine in metastasizing carcinoid of the small intestine]. Helv Med Acta (1955) 0.75
[Physiological and pharmacological significance of cholinesterase and anticholinesterase]. Klin Wochenschr (1958) 0.75
[On the activity of amino acid decarboxylases in the brain of man]. Helv Physiol Pharmacol Acta (1961) 0.75
[Not Available]. Schweiz Med Wochenschr (1955) 0.75
Nerve conduction in the absence of cholinesterase activity induced by di-isopropyl fluorophosphate. Fed Proc (1946) 0.75
Cholinesterases of the central nervous system. J Neuropathol Exp Neurol (1955) 0.75
Cardiovascular and oxytocic actions of a series of quinoline derivatives. J Pharmacol Exp Ther (1954) 0.75
Protection of cholinesterase against irreversible inactivation by di-isopropyl fluorophosphate in vitro. J Pharmacol Exp Ther (1946) 0.75
[Effects of nucleic acids alone and in combination with the heart glycoside convallatoxin on the isolated frog heart]. Helv Physiol Pharmacol Acta (1951) 0.75
Spontaneous increase in the rate of formation of methionine from dimethylthetin and homocysteine in rat liver homogenates. Arch Biochem Biophys (1951) 0.75
The effect of single intravenous and oral doses of McN-181 (1,4-bis (1,4-benzodioxan-2-ylmethyl) piperazine) upon the blood pressure of hypertensive subjects. Am J Med Sci (1954) 0.75
The chronic toxicity of di-isopropyl fluorophosphate (DFP) in dogs, monkeys and rats. J Pharmacol Exp Ther (1946) 0.75
Pharmacological approaches to the study of tranquilizing agents. Psychiatr Res Rep Am Psychiatr Assoc (1958) 0.75
The chronic toxicity of di-isopropyl fluorophosphate in dogs, monkeys and rats. Fed Proc (1946) 0.75
Transmission of impulses in peripheral nerves treated with di-isopropyl fluorphosphate. J Neurophysiol (1946) 0.75
The localization of specific cholinesterase in the retina. Pharmacol Rev (1954) 0.75
[Not Available]. Schweiz Med Wochenschr (1950) 0.75
The effects of intravenous infusions of the optical isomers of dibozane (McN-181;1,4-bis[1,4-benzodioxan-2-ylmethyl] piperazine), an adrenergic blocking agent, upon hypertensive subjects. Am J Med Sci (1954) 0.75
The histochemical differentiation of types of cholinesterase and their distributions in the tissues of the cat. Bull Johns Hopkins Hosp (1950) 0.75
The localizanon or acetylcholinesterase in neurons. Prog Neurobiol (1957) 0.75
The pharmacology of di-isopropyl fluorophosphate in man. J Pharmacol Exp Ther (1946) 0.75
Pharmacologic significance of inhibition of monomine oxidase. J Clin Exp Psychopathol (1958) 0.75
The coming of age of therapeutics. Am J Pharm Sci Support Public Health (1963) 0.75
[Not Available]. Schweiz Med Wochenschr (1949) 0.75
The pharmacology of mescaline and D-lysergic acid diethylamide (LSD). N Engl J Med (1958) 0.75